世索科二季度业绩同比下降

Core Insights - The core viewpoint of the article highlights the financial performance of Solvay in Q2 2025, indicating a mixed performance with a decline in EBITDA year-over-year but an increase quarter-over-quarter [1] Financial Performance - EBITDA reached €335 million, representing an 8% year-over-year decline but an 8% quarter-over-quarter increase [1] - Net sales amounted to €1.59 billion, with the consumer and industrial specialty chemicals segment showing year-over-year growth [1] - Gross profit was €506 million, down 13% year-over-year, with a gross margin of 31.9%, reflecting a 20 basis points increase quarter-over-quarter [1] - EBITDA margin contracted by 110 basis points year-over-year to 21.1%, but improved by 190 basis points quarter-over-quarter [1] - Basic net profit stood at €140 million [1] Management Commentary - The CEO of Solvay, Dr. Ilham Kadri, stated that the company met expectations in a challenging macroeconomic environment and plans to accelerate cost-saving measures in the second half of the year to support long-term profitability growth [1]